SUN vs. DEMG, MHC, RUA, POLX, BELL, FAB, OCTP, IQAI, IXI, and HELD
Should you be buying Surgical Innovations Group stock or one of its competitors? The main competitors of Surgical Innovations Group include Deltex Medical Group (DEMG), MyHealthChecked (MHC), RUA Life Sciences (RUA), Polarean Imaging (POLX), Belluscura (BELL), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IQ-AI (IQAI), IXICO (IXI), and Hellenic Dynamics (HELD). These companies are all part of the "medical" sector.
Deltex Medical Group (LON:DEMG) and Surgical Innovations Group (LON:SUN) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, community ranking, dividends, profitability, media sentiment, valuation, institutional ownership, earnings and analyst recommendations.
In the previous week, Surgical Innovations Group had 9 more articles in the media than Deltex Medical Group. MarketBeat recorded 9 mentions for Surgical Innovations Group and 0 mentions for Deltex Medical Group. Deltex Medical Group's average media sentiment score of 0.17 beat Surgical Innovations Group's score of 0.00 indicating that Surgical Innovations Group is being referred to more favorably in the news media.
Surgical Innovations Group has a net margin of -0.83% compared to Surgical Innovations Group's net margin of -42.80%. Deltex Medical Group's return on equity of -0.90% beat Surgical Innovations Group's return on equity.
17.5% of Deltex Medical Group shares are owned by institutional investors. Comparatively, 43.7% of Surgical Innovations Group shares are owned by institutional investors. 67.0% of Deltex Medical Group shares are owned by company insiders. Comparatively, 46.2% of Surgical Innovations Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Surgical Innovations Group has higher revenue and earnings than Deltex Medical Group.
Surgical Innovations Group received 62 more outperform votes than Deltex Medical Group when rated by MarketBeat users. Likewise, 68.36% of users gave Surgical Innovations Group an outperform vote while only 64.84% of users gave Deltex Medical Group an outperform vote.
Deltex Medical Group has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, Surgical Innovations Group has a beta of 0.35, indicating that its stock price is 65% less volatile than the S&P 500.
Summary
Surgical Innovations Group beats Deltex Medical Group on 9 of the 13 factors compared between the two stocks.
Get Surgical Innovations Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SUN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart
Surgical Innovations Group Competitors List
Related Companies and Tools